Bone disease in patients with primary sclerosing cholangitis: prevalence, severity and prediction of progression.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of Hepatology

• Publication date

  1998-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0168-8278(98)80253-5PMID 9833910
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reduced bone density in patients with inflammatory bowel disease.

  1997cited by this paper
• Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group.

  1997cited by this paper
• Ursodiol for Primary Sclerosing Cholangitis

  1997cited by this paper
• Colitis causes bone loss in rats through suppression of bone formation.

  1996cited by this paper
• Metabolic bone assessment in patients with inflammatory bowel disease.

  1995cited by this paper
• Bone disease in primary biliary cirrhosis: Does ursodeoxycholic acid make a difference?

  1995cited by this paper
• The evaluation of osteoporosis : dual energy x-ray absorptiometry in clinical practice

  1994cited by this paper
• Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis.

  1994cited by this paper
• Primary sclerosing cholangitis: refinement and validation of survival models.

  1992cited by this paper
• Longitudinal study of cortical bone loss in patients with inflammatory bowel disease.

  1992cited by this paper
• Bone disease after liver transplantation.

  1992cited by this paper
• Low bone mineral density in patients with inflammatory bowel disease

  1992cited by this paper
• Diagnosis of Osteoporosis

  1992cited by this paper
• Bone disease in liver transplant recipients: incidence, timing, and risk factors.

  1991cited by this paper
• The metabolic bone disease of primary sclerosing cholangitis

  1991cited by this paper
• Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis

  1991cited by this paper
• Prevalence and prediction of osteopenia in chronic liver disease

  1990cited by this paper
• Biochemical markers of bone turnover for the clinical assessment of metabolic bone disease.

  1990cited by this paper
• Factors influencing the development of metabolic bone disease in primary biliary cirrhosis.

  1990cited by this paper
• Glucocorticoid-induced osteoporosis: pathogenesis and management.

  1990cited by this paper
• Bone disease after orthotopic liver transplantation.

  1988cited by this paper
• Interleukin‐1β is a potent inhibitor of bone formation in vitro

  1987cited by this paper
• Osteoporosis in patients with inflammatory bowel disease.

  1987cited by this paper
• Tumor necrosis factor-alpha (cachectin) stimulates bone resorption in mouse calvaria via a prostaglandin-mediated mechanism.

  1987cited by this paper
• Interleukin-1 beta is a potent inhibitor of bone formation in vitro.

  1987cited by this paper
• Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors

  1986cited by this paper
• Osteoblasts mediate interleukin 1 stimulation of bone resorption by rat osteoclasts

  1986cited by this paper
• Changes in bone mineral density of the proximal femur and spine with aging. Differences between the postmenopausal and senile osteoporosis syndromes.

  1982cited by this paper
• Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis

  1981cited by this paper

• Mendelian randomization to evaluate the causal relationship between liver enzymes and the risk of six specific bone and joint-related diseases

  2023cites this paper
• Osteoporosis and Fragility Fractures in Patients with Liver Cirrhosis: Usefulness of FRAX® as a Screening Tool

  2023cites this paper
• Vitamin D Deficiency in Chronic Childhood Disorders: Importance of Screening and Prevention

  2023cites this paper
• A Systematic Review and Meta-Analysis on Metabolic Bone Disease in Patients with Primary Sclerosing Cholangitis

  2022cites this paper
• Osteosarcopenia in autoimmune cholestatic liver diseases: Causes, management, and challenges

  2022cites this paper
• Os et foie

  2021cites this paper
• Preventative care in cholestatic liver disease: Pearls for the specialist and subspecialist☆

  2019cites this paper
• Primary Sclerosing Cholangitis: A Concise Review of Diagnosis and Management

  2019cites this paper
• British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis

  2019cites this paper
• Hepatic Osteodystrophy—Molecular Mechanisms Proposed to Favor Its Development

  2019influential citation
• Osteoporosis in chronic liver disease

  2018cites this paper
• Clinical guidelines for primary sclerosing cholangitis 2017

  2018cites this paper
• Risk factors for osteoporosis in liver cirrhosis patients measured by transient elastography

  2018cites this paper
• Jaundice and Cholestasis

  2018cites this paper
• Complications, symptoms, quality of life and pregnancy in cholestatic liver disease

  2018cites this paper
• Primary Sclerosing Cholangitis: What the Gastroenterologist and Hepatologist Needs to Know.

  2017cites this paper
• The Challenges of Nutritional Assessment in Cirrhosis

  2017cites this paper
• Diffusion-weighted MRI for detection of hepatic osteodystrophy in primary sclerosing cholangitis: a comparison study with dual-energy X-ray absorptiometry

  2016cites this paper
• Fracture risk calculation tool enhances dual-energy X-ray absorptiometry scan referral pathway in cirrhosis patients

  2016cites this paper
• Crucial Role of Vitamin D in the Musculoskeletal System

  2016cites this paper
• Prospective study of profile of hepatic osteodystrophy in patients with non-choleastatic liver cirrhosis and impact of bisphosphonate supplementation

  2016cites this paper
• Risk factors for osteoporosis in patients with end-stage liver disease.

  2016cites this paper
• Chapter 14 – Transplantation for Sclerosing Cholangitis

  2015cites this paper
• Bone disease in cirrhosis

  2015cites this paper
• ACG Clinical Guideline: Primary Sclerosing Cholangitis

  2015cites this paper
• In Memoriam Paul Angulo.

  2015cites this paper
• PRIMARNI SKLEROZIRAJUĆI KOLANGITIS

  2015cites this paper
• Osteoporosis and fractures in liver disease: relevance, pathogenesis and therapeutic implications.

  2014cites this paper
• Pierwotne stwardniające zapalenia przewodów żółciowych – znaczenie czynników żywieniowych

  2014cites this paper
• Early diagnosis and treatment of rheumatoid arthritis in primary health care

  2014cites this paper
• Is alanine aminotransferase associated with osteopenia in middle-aged and elderly Chinese?

  2014cites this paper
• Hepatic osteodystrophy.

  2014influential citation
• Evidence of degraded BMD and geometry at the proximal femora in male patients with alcoholic liver cirrhosis

  2014cites this paper
• Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis: a Review Featuring a Women's Health Perspective

  2014influential citation
• The risk of fractures among patients with cirrhosis or chronic pancreatitis.

  2014cites this paper
• Os et foie

  2013cites this paper
• Osteodystrophy in chronic liver diseases

  2013cites this paper
• Primary sclerosing cholangitis.

  2013cites this paper
• Association of nonalcoholic fatty liver disease with low bone mass in postmenopausal women

  2012cites this paper
• 10 – Diseases of the bile ducts

  2012cites this paper
• Primary Sclerosing Cholangitis: Is Any Treatment Worthwhile?

  2012cites this paper
• Extraintestinal Manifestations of Inflammatory Bowel Disease: Primary Sclerosing Cholangitis

  2012cites this paper
• Hepatic osteodystrophy: An important matter for consideration in chronic liver disease.

  2011cites this paper
• Bone disease in patients with primary sclerosing cholangitis.

  2011cites this paper
• Classical and Emerging Roles of Vitamin D in Hepatitis C Virus Infection

  2011cites this paper
• Systematic review: management options for primary sclerosing cholangitis and its variant forms – IgG4‐associated cholangitis and overlap with autoimmune hepatitis

  2011cites this paper
• Bone Disorders in Chronic Liver Diseases

  2011cites this paper
• Jaundice and Cholestasis

  2011cites this paper
• Osteoporosis in Non Cholestatic Decompensated Chronic Liver Disease and Its co-relation with Vitamin D and Parathyroid Hormone Levels

  2011cites this paper
• Primary sclerosing cholangitis: overview and update

  2010cites this paper
• Liver and bone.

  2010cites this paper
• Sclerosing Cholangitis and Recurrent Pyogenic Cholangitis

  2010cites this paper
• Treatment options for primary sclerosing cholangitis

  2010cites this paper
• Latest and Emerging Therapies for Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis

  2010cites this paper
• Diagnosis and management of primary sclerosing cholangitis

  2010cites this paper
• Clinical features and management of primary sclerosing cholangitis.

  2008cites this paper
• Current diagnosis and management of primary sclerosing cholangitis

  2008cites this paper
• Primary sclerosing cholangitis.

  2008cites this paper
• Primary sclerosing cholangitis.

  2008cites this paper
• Bone disorders in chronic liver disease

  2007cites this paper
• Current treatments of primary sclerosing cholangitis.

  2007cites this paper
• The Medical Management of Primary Sclerosing Cholangitis

  2006cites this paper
• Is significant cystic fibrosis‐related liver disease a risk factor in the development of bone mineralization abnormalities?

  2006cites this paper
• Management Of Primary Sclerosing Cholangitis.

  2006cites this paper
• Treatment of bone disorders in liver disease.

  2006cites this paper
• Bone mineral density before and after OLT: Long‐term follow‐up and predictive factors

  2006cites this paper
• The medical management of primary sclerosing cholangitis.

  2006cites this paper
• Assessment of bone metabolism and mineral density in chronic viral hepatitis.

  2006cites this paper
• Severity of liver disease does not predict osteopenia or low bone mineral density in primary sclerosing cholangitis

  2005influential citation
• Treatment of biliary problems in inflammatory bowel disease

  2005cites this paper
• Evaluation and management of osteoporosis in liver disease.

  2005cites this paper
• Alendronate in combination with calcium and vitamin D prevents bone loss after orthotopic liver transplantation: A prospective single‐center study

  2005cites this paper
• Transplantation for Sclerosing Cholangitis

  2005cites this paper
• Extraintestinal manifestations in inflammatory bowel disease.

  2005cites this paper
• Bone mineral density among cirrhotic patients awaiting liver transplantation

  2004cites this paper
• Primary sclerosing cholangitis.

  2004cites this paper
• Bone Abnormalities in Gastrointestinal and Hepatic Disease

  2004cites this paper
• Low bone mineral density in noncholestatic liver cirrhosis: prevalence, severity and prediction.

  2003cites this paper
• AGA technical review on osteoporosis in hepatic disorders.

  2003cites this paper
• Metabolic bone disease in patients with liver disease

  2003cites this paper
• Current management of primary biliary cirrhosis and primary sclerosing cholangitis.

  2003cites this paper
• Treatment options for primary biliary cirrhosis and primary sclerosing cholangitis

  2003cites this paper
• Bone metabolism in advanced cholestatic liver disease: Analysis by bone histomorphometry

  2002cites this paper
• Guidelines on the management of osteoporosis associated with chronic liver disease

  2002cites this paper
• Bone involvement in patients with chronic cholestasis.

  2002cites this paper
• L’atteinte osseuse dans les maladies chroniques cholestatiques

  2002cites this paper
• Hepatobiliary disease in inflammatory bowel disease.

  2002cites this paper
• Increased rate of bone loss at the femoral neck in patients with chronic liver disease

  2002cites this paper
• Bone involvement in patients with chronic cholestasis.

  2002cites this paper
• Primary sclerosing cholangitis.

  2002cites this paper
• An Update on Bone Abnormalities Associated with Gastrointestinal and Liver Disease

  2001cites this paper
• Drug therapy of primary biliary diseases: classical and modern strategies

  2001cites this paper
• Autoimmune liver disease. Current standards, future directions.

  2001cites this paper
• Osteoporosis in Chronic Liver Disease

  2001influential citation
• Medical Treatment of Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis

  2001cites this paper
• Primary sclerosing cholangitis

  2001cites this paper
• Management of primary sclerosing cholangitis in adults

  2000cites this paper
• Neoplastic and other complications of inflammatory bowel disease

  2000cites this paper
• Future directions in the medical treatment of primary sclerosing cholangitis: the need for combination drug therapy

  2000cites this paper
• Failure of budesonide in a pilot study of treatment-dependent autoimmune hepatitis.

  2000cites this paper